The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...

A new randomized clinical trial finds that simple reminder emails substantially increase clinicians' use of a database that ...